Effectiveness of the drugs of streptomycin group in experimental studies on albino mice infected with Mycobacterium tuberculosis resistant to these drugs
Kozulitsyna, T.I.; Kozlova, N.V.
Problemy Tuberkuleza 9: 70-74
1976
ISSN/ISBN: 0032-9533 PMID: 64981 Document Number: 108450
Document emailed within 1 workday
Related Documents
Srivastava, S.; Ayyagari, A.; Dhole, T.N.; Krishnani, N.; Nyati, K.K.; Dwivedi, S.K. 2008: Progression of chronic pulmonary tuberculosis in mice intravenously infected with ethambutol resistant Mycobacterium tuberculosis Indian Journal of Medical Microbiology 26(4): 342-348Vladimirskiĭ, M.A.; Ladygina, G.A.; Tentsova, A.I. 1983: Effectiveness of liposome-incorporated streptomycin in experimental tuberculosis in mice Antibiotiki 28(1): 23-26
Kondo, E.; Kanai, K. 1977: Experimental studies on the effective regimens of antituberculous drugs in the treatment of tuberculosis. II. Long-term chemotherapy in mice by daily and intermittent administration with changing drug combination Kekkaku: 52(8): 373-376
Brel, F.; Rabaud, C.; May, T.; Hoen, B.; Amiel, C.; Burty, C.; Dailloux, M.; Canton, P. 1995: Isolation of an acid-alcohol resistant bacillus (BAAR) in the febrile HIV infected patients: Mycobacterium tuberculosis (MT) or Mycobacterium avium complex (MAC)? Pathologie-Biologie 43(4): 380-384
Kameda, K.; Kudo, S.; Iwai, K.; Ushikubo, K. 1970: Studies on tubercle bacilli resistant to secondary drugs in the resected specimens and sputum of pulmonary tuberculosis patients Kekkaku: 45(9): 283-287
Navalkar, R.G.; Patel, P.J.; Dalvi, R.R.; Kanchana, M.V. 1976: Electrophoretic patterns of serum proteins and immunoglobulin levels in mycobacterial infections--studies in mice infected with mycobacterium leprae and mycobacterium lepraemurium Journal of the National Medical Association 68(6): 500
Kabedi, M.J.; Kashongwe, M.; Kayembe, J.M.; Mumba Ngoyi, D.; Mampasi, P.; Mbaya, P.; Fissette, K.; Verhaegen, J.; Portaels, F.; Muyembe-Tamfum, J.J. 2007: Primary resistance of Mycobacterium tuberculosis to anti-tuberculosis drugs in Kinshasa, (DRC) Bulletin de la Societe de Pathologie Exotique 100(4): 275-276
Sayğan, M.B.; Ocak, F.; Cesur, S.; Tarhan, G.ül.; Ceyhan, I.; Gümüişlü, F.; Beker, G.ül.şa.; Güner, U.ğu.; Coşkun, E. 2007: Susceptibilities of Mycobacterium tuberculosis strains collected from regional tuberculosis laboratories to major antituberculous drugs Mikrobiyoloji Bulteni 41(3): 403-409
Martínez-Abraján, D.M. 1993: Differential specific humoral response of susceptible and resistant mice infected with Mycobacterium lepraemurium Revista Latinoamericana de Microbiologia 35(2): 171-176
Moisa, I.; Demetrescu, R. 1970: Comparative studies of the susceptibility of some lines of mice to influenza viruses. I. Experimental study of some strains of type a and A2 in A2G, CBA, C3H (hybrid) and albino mice Studii Si Cercetari de Inframicrobiologie 21(2): 111-117
Pershin, G.N.; Zykova, T.N.; Kutchak, S.N. 1977: Combination therapy with butomelide and rifampicin in experimental tuberculosis in albino mice Problemy Tuberkuleza 1: 64-69
Cardona, P.J.; Llatjós, R.; Gordillo, S.; Díaz, J.; Ojanguren, I.; Ariza, A.; Ausina, V. 2000: Evolution of granulomas in lungs of mice infected aerogenically with Mycobacterium tuberculosis Scandinavian Journal of Immunology 52(2): 156-163
Rao, N.A. 2007: New drugs in resistant tuberculosis JPMA. Journal of the Pakistan Medical Association 57(5): 252-256
Ryzhkova, V.V.; Pavlovich, N.V.; Makarovskaia, L.N.; Zurabian, V.A.; Bespalova, I.A.; Goncharov, E.K.; Bugaeva, O.K.; Malsova, N.N. 1996: Increased effectiveness of etiotropic therapy of experimental plague in albino mice at the stage of generalized infection Antibiotiki i Khimioterapiia 41(2): 35-39
Bouvet, Él. 2014: New drugs against multidrug-resistant tuberculosis La Revue du Praticien 64(7): 896-897
Baska, F.; Székely, E.R.; Szántai-Kis, C.; Bánhegyi, P.ét.; Hegymegi-Barakonyi, B.ál.; Németh, G.áb.; Breza, N.ór.; Zsákai, L.; Greff, Z.án.; Pató, J.án.; Kéri, G.ör.; Orfi, L.ás. 2013: Development and study of structure-activity relationship of drugs against Mycobacterium tuberculosis Acta Pharmaceutica Hungarica 83(3): 88-95
Homolka, J.; Krejbich, F.; Havelková, M. 2004: Resistance of Mycobacterium tuberculosis to antituberculotic drugs in Czech Republic in 2003 Casopis Lekaru Ceskych 143(12): 836-839
Koval'chuk, L.V.; Gvozdeva, I.V.; Chernousova, L.N.; Gankovskaia, L.V.; Smirnova, T.G.; Larionova, E.E.; Sokolova, E.V.; Levchenko, V.A. 2010: Regulatory effect of complex of natural cytokines and antimicrobial peptides on murine macrophages infected with multidrug-resistant Mycobacterium tuberculosis Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 3: 52-55
Delás, M.A.; Martínez, C.; Yagüe, C.; Rodríguez, T.; Rodríguez, T.; Segovia, M. 2001: Comparative study of 3 tests for susceptibility of Mycobacterium tuberculosis to first-line antituberculous drugs Revista Espanola de Quimioterapia: Publicacion Oficial de la Sociedad Espanola de Quimioterapia 14(1): 40-46
Djiba, M.L.; Sow, A.I.; Ndiaye, M.; Dromigny, J.A. 2004: Evaluation of E-test method in determination of susceptibility of Mycobacterium tuberculosis to four antituberculosis drugs Dakar Medical 49(3): 185-191